» Articles » PMID: 20227547

Effect of Low-dose Combined Oral Contraceptive on Aerobic Capacity and Anaerobic Threshold Level in Active and Sedentary Young Women

Overview
Journal Contraception
Publisher Elsevier
Date 2010 Mar 16
PMID 20227547
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to evaluate the effect of long-term use of oral contraceptives (OC) containing 0.20 mg of ethinylestradiol (EE) combined with 0.15 mg of gestodene (GEST) on the peak aerobic capacity and at the anaerobic threshold (AT) level in active and sedentary young women.

Study Design: Eighty-eight women (23+/-2.1 years old) were divided into four groups - active-OC (G1), active-NOC (G2), sedentary-OC (G3) and sedentary-NOC (G4) - and were submitted to a continuous ergospirometric incremental test on a cycloergometer with 20 to 25 W min(-1) increments. Data were analyzed by two-way ANOVA with Tukey post hoc test. Level of significance was set at 5%.

Results: The OC use effect for the variables relative and absolute oxygen uptake VO(2) mL kg-(1) min(-1); VO(2), L min(-1), respectively), carbon dioxide output (VCO(2), L min(-1)), ventilation (VE, L min(-1)), heart rate (HR, bpm), respiratory exchange ratio (RER) and power output (W) data, as well as the interaction between OC use and exercise effect on the peak of test and at the AT level did not differ significantly between the active groups (G1 and G2) and the sedentary groups (G3 and G4). As to the exercise effect, for all variables studied, it was noted that the active groups presented higher values for the variables VO(2), VCO(2), VE and power output (p<.05) than the sedentary groups. The RER and HR were similar (p>.05) at the peak and at the AT level between G1 vs. G3 and G2 vs. G4.

Conclusions: Long-term use of OC containing EE 0.20 mg plus GEST 0.15 mg does not affect aerobic capacity at the peak and at the AT level of exercise tests.

Citing Articles

Cardiorespiratory response to exercise in endurance-trained premenopausal and postmenopausal females.

Rael B, Barba-Moreno L, Romero-Parra N, Alfaro-Magallanes V, Castro E, Cupeiro R Eur J Appl Physiol. 2021; 121(3):903-913.

PMID: 33389018 DOI: 10.1007/s00421-020-04574-4.


The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis.

Elliott-Sale K, McNulty K, Ansdell P, Goodall S, Hicks K, Thomas K Sports Med. 2020; 50(10):1785-1812.

PMID: 32666247 PMC: 7497464. DOI: 10.1007/s40279-020-01317-5.


Maximal fat oxidation, but not aerobic capacity, is affected by oral contraceptive use in young healthy women.

Isacco L, Thivel D, Pereira B, Duclos M, Boisseau N Eur J Appl Physiol. 2014; 115(5):937-45.

PMID: 25519952 DOI: 10.1007/s00421-014-3075-7.


The comparative study of Yaz and Ovocept-ld on patients with simple ovarian cysts referring to Iran-Isfahan Shariati Hospital.

Riahinejad S, Pour A, Dehghani L, Hajizadeh S Adv Biomed Res. 2014; 3:205.

PMID: 25337535 PMC: 4202506. DOI: 10.4103/2277-9175.142315.